Where Excellence Meets Innovation
The state-of-the-art DNA laboratory at Novogenia is considered one of the leading human genetics laboratories in Europe. With a peak load of 275,000 samples per day and over 35 million PCR analyses conducted, medical professionals worldwide rely on our expertise. Our wide range of services, from genetic to allergy analyses, aims to optimize healthcare through personalized data. Novogenia primarily focuses on prevention and lifestyle genetic tests within its laboratory group.
By using advanced analytical techniques such as microfluidics, DNA microarrays, Sanger sequencing, and agarose gel restriction fragment length polymorphism, we can capture up to 20 million genetic variations per sample. These highly precise DNA analyses also provide valuable insights into non-medical genetic traits such as nutrigenetics, performance enhancement, and skin genetics. This allows Novogenia to offer its customers a comprehensive foundation for optimal healthcare while adhering to the highest standards in process and result safety.
Novogenia specializes in lifestyle genetic tests, utilizing advanced technologies to reveal up to 20 million genetic differences per sample. Our specializations include:
Investigating the impact of calorie types on weight gain, weight loss methods, and genetic factors influencing detoxification and health.
- Performance Genetics
Analyzing genetic performance potential, stress response, and optimal muscle formation.
- Skin Genetics
Genetic characterization of various skin types for personalized skincare.
- Preventive Genetics
Identifying genetic risk factors for common diseases for early detection and prevention.
Examining gene defects affecting drug metabolism for personalized therapy.
Samples and Techniques
Our DNA laboratory processes various samples using advanced techniques:
- Fluorescence Probe Hybridization:
Robust method for analyzing genetic deviations.
- Microfluidic Technique:
Miniaturized genetic tests with high accuracy.
- DNA Microarray:
Customized microarray technology for extensive genetic analysis.
- Sanger Sequencing:
Gold standard in genetics despite complexity and cost.
- Agarose Gel Analysis:
Older technology for cutting small genetic sections with limitations.
WHAT MAKES THE LABORATORY RESULTS SPECIAL
LOW SAMPLE REQUISITION RATES:
- Significant reduction in recall rates at Novogenia
- Industry-wide repeat rate for every 30th customer
- Novogenia rate: 1 in 150, thanks to a mature sample procedure
- Procedure includes drying in the tube, the use of three swabs, and multiple analyses
CLEAR COMMUNICATION THROUGH REPORTS
- Novogenia emphasizes clear reporting
- Goal: Clear and comprehensible reports for both laypersons and professionals
CONTINUOUS REPORT OPTIMIZATION:
- 538 revisions to reports since the company’s inception
- Focus not only on marketing but also on current scientific findings
- Products are continuously adjusted
FROM RISK TO ACTIONABLE GUIDANCE:
- Identifying genetic risks alone is not enough
- Novogenia provides concrete recommendations for a healthier lifestyle
HIGHEST-LEVEL QUALITY CONTROL:
- The laboratory in Austria complies with strict national quality standards
- The company sets its own higher quality standards
- Positive evaluations from external auditors for quality assurance systems
- Use of special software developed by Novogenia for automated quality control
- Ensuring the highest standards in all areas of analysis
Technology and Capacity Over the Years
Our commitment to technological excellence is evident in our laboratory’s evolution over the years:
- High-Resolution Melting Analysis
- 100 genetic analyses per 2-hour cycle
- Capacity: 8,000 genetic analyses per month
- Hybridization Technology with Fluorescent Probes
- 384 genetic analyses per 2-hour cycle
- Fully automated 24/7 operation
- Capacity: 138,000 genetic analyses per month
- Microfluidics Technology
- 9,000 genetic analyses per 2-hour cycle
- Capacity: 720,000 genetic analyses per month
- Microarray Technology
- 15 million genetic analyses per 3-day cycle
- Capacity: 2.2 trillion genetic analyses per month